To test this hypothesis, we examined the expression of NAC1 and BCL6 transcripts in a panel of 7 ovarian cancer cell lines and assessed NAC1 and BCL6 protein expression in 51 high-grade serous ovarian adenocarcinoma samples (Figure 4A and 4C). The gene discussed is BCL6; the disease is ovarian cancer.